Yumanity Therapeutics (YMTX) Insider Trading & Ownership → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free YMTX Stock Alerts $0.62 +0.06 (+10.62%) (As of 05/9/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Yumanity Therapeutics (NASDAQ:YMTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.45%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)5Amount OfInsider Selling(Last 3 Years)$73,329.08 Get YMTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Yumanity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address YMTX Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Yumanity Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2022Michael D WyzgaInsiderSell3,116$1.69$5,266.04 12/2/2022Richard PetersCEOSell10,890$1.69$18,404.10 7/5/2022Richard PetersCEOSell4,584$1.85$8,480.40 6/3/2022Devin Whittemore SmithSVPSell2,923$1.19$3,478.37 6/3/2022Marie EpsteinInsiderSell1,806$1.19$2,149.14 6/3/2022Richard PetersCEOSell10,206$1.19$12,145.14 3/28/2022Richard PetersCEOSell10,715$1.85$19,822.75 2/3/2022Paulash MohsenInsiderSell1,958$1.83$3,583.14 (Data available from 1/1/2013 forward) YMTX Insider Trading Activity - Frequently Asked Questions Who is on Yumanity Therapeutics's Insider Roster? The list of insiders at Yumanity Therapeutics includes Devin Whittemore Smith, Marie Epstein, Michael D Wyzga, Paulash Mohsen, and Richard Peters. Learn more on insiders at YMTX. What percentage of Yumanity Therapeutics stock is owned by insiders? 12.45% of Yumanity Therapeutics stock is owned by insiders. Learn more on YMTX's insider holdings. Which Yumanity Therapeutics insiders have been selling company stock? The following insiders have sold YMTX shares in the last 24 months: Devin Whittemore Smith ($3,478.37), Marie Epstein ($2,149.14), Michael D Wyzga ($5,266.04), and Richard Peters ($39,029.64). How much insider selling is happening at Yumanity Therapeutics? Insiders have sold a total of 33,525 Yumanity Therapeutics shares in the last 24 months for a total of $49,923.19 sold. More Insider Trading Tools from MarketBeat Related Companies: Protagenic Therapeutics Insider Trades Kineta Insider Trades Kintara Therapeutics Insider Trades Processa Pharmaceuticals Insider Trades Hoth Therapeutics Insider Trades Hillstream BioPharma Insider Trades Lixte Biotechnology Insider Trades PaxMedica Insider Trades Sonnet BioTherapeutics Insider Trades Shuttle Pharmaceuticals Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:YMTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetryThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersObama’s Forever Term [exposed]Porter & Company348 million Americans lives to END as we know it?The Oxford ClubProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yumanity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.